Pfizer, DxS To Develop Brain Tumor Companion Diagnostic Kit
Published: 05-Feb-2010
Pfizer and DxS, a wholly-owned subsidiary of Qiagen, have collaborated to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM).
The Qiagen assay is designed to identify those patients whose tumors express the EGFRvIII mutation, allowing for the possibility of more targeted and personalised treatment.
The company said that the EGFRvIII companion diagnostic will be developed and manufactured at Qiagen’s Center of Excellence for Companion Diagnostics in Manchester. The diagnostic will be a real-time PCR assay used to detect EGFRvIII RNA in tumor tissue. The assay is designed to offer a simple workflow, which supports its clinical utility in routine mutation testing.
Stephen Little, vice president of personalized healthcare at Qiagen, said: “We are pleased to have signed this agreement with Pfizer, as it is another important step toward the realisation of personalised medicine. Qiagen is aligned to deliver companion diagnostics to our pharmaceutical partners and this deal is further evidence of our commitment to develop our scientific and operational capabilities to help select the right patient for the right medicine.”
Garry Nicholson, president and general manager of oncology business unit at Pfizer, said: “We look forward to collaborating with Qiagen's DxS unit in the development of this important diagnostic tool that could potentially help physicians better define the most appropriate treatment for patients who suffer from glioblastoma multiforme.”
Network Sites

Suppliers To This Sector
Browse A-Z
ARTES Biotechnology
Services for Recombinant Strain Development in Microbial Expression Systems ...
Aries Medical Knowledge
Knowledge Finder, Editorial Manager and DocuRights ...
Asa Medical Laser Srl overview
To produce this energy every day and keep it under control. ...
Tecvac
Hard Coating and Heat Treatment Services ...
CareFusion
Improving Patient Care ...
Sparta Systems Europe
The Leader in Enterprise Quality Management Solutions ...
White Papers
Browse A-Z
Operating Principle and Construction of Zirconium Dioxide Oxygen Sensors
Sensortechnics' oxygen sensors of the XYA series consist of two zirconium dioxide (ZrO2) d ...
TNO Pharma Services: From Discovery to the Clinic
Our kinetics & metabolism experts can help you select and further develop your candidate d ...
Titanium Nitride (TiN)
Free white paper fact sheet on Tecvac's Titanium Nitride (TiN) product. ...
Designing Fail-Safe Storage for Embedded Systems
HCC-Embedded has spent significant time and effort analysing, designing and testing reliab ...
Stimulus Spending Brings Medical Application to Life: Opportunities and Challenges in Digital Records
Governments worldwide are pouring billions of dollars into health information technology. ...
Open, x86 Based Small Form Factor (SFF) Medical Devices are Becoming More Sophisticated
The new generation of low power x86 small form factor processors, available with the 45nm ...


Delicious
Digg
Reddit
Stumble
LinkedIn
Mail sent successfully